Trademark: 97573643
Status Date
Friday, October 13, 2023
Filing Date
Wednesday, August 31, 2022
Abandoned Date
Friday, September 29, 2023
5 Pharmaceuticals for use in the treatment of oncological, autoimmune, infectious, endocrinal, and ocular diseases and disorders; antibodies and protein molecules for use in medical diagnosis and treatment of diseases and disorders
42 Research and development services in the field of antibodies and protein molecules; design and development of antibodies and protein molecules for research, diagnostic and therapeutic applications
Oct 16, 2023
Abandonment Notice E-Mailed - Failure To Respond
Oct 13, 2023
Abandonment Notice Mailed - Failure To Respond
Oct 13, 2023
Abandonment - Failure To Respond Or Late Response
Jun 28, 2023
Notification Of Non-Final Action E-Mailed
Jun 28, 2023
Non-Final Action E-Mailed
Jun 28, 2023
Non-Final Action Written
Jun 15, 2023
Assigned To Examiner
Sep 7, 2022
New Application Office Supplied Data Entered
Sep 3, 2022
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24